Anal Fissure, Hemorrhoids, Perianal Fistula
Conditions
Brief summary
New produced and patented sodium pantaborat based gel will be use for treatment of benign perianal diseases (hemooroidal disease, anal fissura anda perianal fistula)
Detailed description
Prospective randomised clinical trial planned. Older than 18 years old perianal benign diseases (grade 1 and 2 hemorroidal disease, anal fissura, uncomplicated simple perianal fistula) cases without malign tumour, cronic colorectal disases, and routine used of vasoactive medication cases were entered the study. Younger than 18 years old, diagnosed any malign tumor and/or cronic colorectal disaeses, routine used of vasoact,ve mediaction cases were exclused of the study. Group-1 (n: 50): Healthy cases (control group) Group-2 (n:50): Grade 1 hemorroidal disease cases Group-3 (n:50): Grade 2 hemorroidal disease cases Group-4 (n:50): Anal fissure cases Group-5 (n:50): Uncomplicated, simple perianal fistula cases
Interventions
Life7 will used on the perianal skin with finger tips
Sponsors
Study design
Eligibility
Inclusion criteria
* Grade 1 and 2 hemorroidal disease * Cronic anal fissura * Uncomplicated simple perianal fistula
Exclusion criteria
* Any malign tumour * Cronic colorectal disases * Routine used of vasoactive medication
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Lowering of leakage amount of perianal fistule | six months | Three grade: lower, same, more |
| Pain symtom differences | six months | Pain Scale from level 1 to level 10. |
| Lowering of the grade of the hemorroidal disease (hemoroidal disease is four grades; grade 1, grade 2, grade 3, and grade 4) | six months | Surgeon general physical examination |
| Closing of anal fissur line | six months | Surgeon general physical examination. Fissur line is exist or not exist |